APA Alıntı

Kamezaki, H., Kanda, T., Arai, M., Wu, S., Nakamoto, S., Chiba, T., . . . Yokosuka, O. (2013). Adherence to Medication Is a More Important Contributor to Viral Breakthrough in Chronic Hepatitis B Patients Treated with Entecavir Than in Those with Lamivudine. Ivyspring International Publisher.

Chicago Stili Alıntı

Kamezaki, Hidehiro, et al. Adherence to Medication Is a More Important Contributor to Viral Breakthrough in Chronic Hepatitis B Patients Treated With Entecavir Than in Those With Lamivudine. Ivyspring International Publisher, 2013.

MLA Alıntı

Kamezaki, Hidehiro, et al. Adherence to Medication Is a More Important Contributor to Viral Breakthrough in Chronic Hepatitis B Patients Treated With Entecavir Than in Those With Lamivudine. Ivyspring International Publisher, 2013.

Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..